Predictive Oncology Inc. Issues Shareholder Letter Titled, "Revolutionizing Medicine: AI-Driven Biomarker and Drug Discovery for Precision Health"
Provided By GlobeNewswire
Last update: May 20, 2025
Latest developments expand Predictive’s AI-driven drug discovery platform to include biomarker discovery and drug repurposing
With the global biomarker discovery market valued at $14.5 billion in 2024 and projected to grow at a 19.4% CAGR through 2030, Predictive Oncology is poised to lead in precision oncology innovation
Read more at globenewswire.com
